Latest news with #PaulRuh
Yahoo
08-05-2025
- Business
- Yahoo
Barbie maker Mattel taps Kenvue's Paul Ruh as CFO
(Reuters) -Mattel on Thursday named consumer health giant Kenvue's Paul Ruh as CFO, replacing Anthony DiSilvestro. Ruh was the finance chief of the Tylenol maker following its spinoff from drug and medical device maker Johnson & Johnson in 2023. He was replaced by Kellanova's Amit Banati as CFO earlier on Thursday. Ruh also spent 13 years at snacks giant PepsiCo. DiSilvestro said in January that he would retire as finance chief of the toymaker after a little over five years in the role. He will stay on as adviser until August 15, the company said in a statement. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Reuters
08-05-2025
- Business
- Reuters
Barbie maker Mattel taps Kenvue's Paul Ruh as CFO
May 8 (Reuters) - Mattel (MAT.O), opens new tab on Thursday named consumer health giant Kenvue's (KVUE.N), opens new tab Paul Ruh as CFO, replacing Anthony DiSilvestro. Ruh was the finance chief of the Tylenol maker following its spinoff from drug and medical device maker Johnson & Johnson (JNJ.N), opens new tab in 2023. He was replaced by Kellanova's Amit Banati as CFO earlier on Thursday. Ruh also spent 13 years at snacks giant PepsiCo (PEP.O), opens new tab. DiSilvestro said in January that he would retire as finance chief of the toymaker after a little over five years in the role. He will stay on as adviser until August 15, the company said in a statement.
Bloomberg
08-05-2025
- Business
- Bloomberg
Mattel Names Paul Ruh CFO, Replacing Anthony DiSilvestro
Mattel Inc. has appointed Paul Ruh as chief financial officer, succeeding Anthony DiSilvestro. Ruh, the former CFO of the consumer healthcare giant Kenvue Inc., will join Mattel on May 19, according to a statement Thursday. DiSilvestro will retire from the maker of Barbie dolls and Hot Wheels miniature cars in August, and will advise the company through the transition.
Yahoo
08-05-2025
- Business
- Yahoo
Listerine, Tylenol Maker Kenvue Tops Estimates, Lifts Sales Outlook
Shares of Kenvue (KVUE) rose in premarket trading Thursday after the maker of Band-Aid, Tylenol, and Listerine reported first-quarter results better than analysts' estimates. The former consumer-focused segment of Johnson & Johnson (JNJ) reported adjusted earnings per share of $0.24 on net sales of $3.74 billion. Both metrics declined from a year ago but by less than analysts polled by Visible Alpha had projected. The consumer products maker said it now expects 2025 net sales growth of 1% to 3%, up from its prior forecast of between a 1% decline and a 1% increase. However, adjusted operating income margin is expected to decline rather than improve, "reflecting the estimated impact of tariffs," while adjusted EPS is projected to be "about flat," down from flat to a 2% increase. Kenvue said it is "working to reduce the financial impact of tariffs through a number of mitigation actions." Separately, Kenvue said Amit Banati will succeed Paul Ruh as CFO, effective next Monday. Banati most recently was CFO at cereal maker Kellanova (K). Kenvue shares were up 5% about an hour before the opening bell. They entered Thursday up about 8% this year. Read the original article on Investopedia
Yahoo
13-02-2025
- Business
- Yahoo
Kenvue to Webcast Presentation at the Consumer Analyst Group of New York Conference
SKILLMAN, N.J., February 13, 2025--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE) today announced Thibaut Mongon, Chief Executive Officer, Paul Ruh, Chief Financial Officer, and Charmaine England, Chief Growth Officer, will present at the Consumer Analyst Group of New York (CAGNY) Conference on Wednesday, February 19, 2025, at 3:00 p.m. Eastern Time. A live webcast of the presentation will be available on and a replay will be available on the website following the event. About Kenvue Kenvue Inc. is the world's largest pure-play consumer health company by revenue. Built on more than a century of heritage, our iconic brands, including Aveeno®, BAND-AID® Brand, Johnson's®, Listerine®, Neutrogena® and Tylenol®, are science-backed and recommended by healthcare professionals around the world. At Kenvue, we realize the extraordinary power of everyday care. Our teams work every day to put that power in consumers' hands and earn a place in their hearts and homes. Learn more at View source version on Contacts Investor Relations: Sofya TsinisKenvue_IR@ Media Relations: Melissa WittMedia@ Sign in to access your portfolio
